University of Birmingham spin-out secures £2m to develop medical diagnostic technology
Image Left to right: Junior Research Scientist Jake Cotterill, Research Scientist Lorea Orueta, Linear Diagnostics Ltd Chief…
read moreOliver invests from UKI2S, an early stage seed/series A fund that backs companies developing complex science and engineering led solutions to global challenges. Specialising in life science investments Oliver joined UKI2S in 2014. He has therapeutic, med tech, agritech and industrial biotech companies in the portfolio and sits on the board of Ikarovec, a gene therapy company and Gyreox, a macrocycle company as well as observer positions at the cell therapy company Cytox.
Prior to joining UKI2S Oliver managed commercialisation of bioengineering and medical technologies at Imperial Innovations and worked at Ark Therapeutics as well as managing a team of biotech buy-side analysts.
Position Investment Director
Telephone 0121 710 1990
“Turning world-leading research into profitable companies is no simple matter, but we are now at a point where many of those technologies are suitable for broad commercial application. The UK Innovation & Science Seed Fund is providing not just capital, but the expertise and the networks to maximize the chances of success in existing markets and in the new markets that synthetic biology enables.”
Image Left to right: Junior Research Scientist Jake Cotterill, Research Scientist Lorea Orueta, Linear Diagnostics Ltd Chief…
read moreAcquisition furthers Astellas’ commitment to innovation in ophthalmology with addition of novel gene therapy program…
read moreBanana plantations in Australia, south-east Asia, Africa and the Middle East have been ravaged by…
read more8th May 2017 Nemesis Bioscience today announced the successful completion of its latest funding round,…
read more13 October 2015 Participation will aid comparison of SNP genotyping with biomarker status Cytox Ltd,…
read moreLondon-based Synthace provides next-generation software and processes to exponentially improve productivity in bioscience, enabling people…
read moreSummary: ZuvaSyntha is developing proprietary renewable manufacturing routes to industrial chemicals from low cost feedstocks…
read moreWhen we talk about the tech revolution that is currently sweeping the industrialised world,…
read moreUpdate your browser to view this website correctly.Update my browser now